ControversiesChallengesConsensus
}

First case experience presented with next generation conformable EVAR device

2018-04-27T09:29:05+01:00

CX delegates were presented data from the first 10 EVAR patients treated using a new conformable device, the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis with active control system, yesterday.

Robert Rhee (Brooklyn, New York), the national principal investigator of the US investigational device exemption (IDE) trial for […]

First case experience presented with next generation conformable EVAR device2018-04-27T09:29:05+01:00

Live cases to illustrate the data: The future of the Charing Cross Symposium

2018-04-27T09:06:25+01:00

In yesterday’s plenary programmes, the future of the Charing Symposium was launched with the initiation of live case demonstrations to illustrate key data discussed on the programme. This year, both the Thoracic Aortic programme and the Peripheral Critical Ischaemia programme featured these illuminating cases, which stirred discussion and […]

Live cases to illustrate the data: The future of the Charing Cross Symposium2018-04-27T09:06:25+01:00

STEP seeks to advance patient safety after TEVAR

2018-04-27T10:06:45+01:00

Stroke is a major concern following TEVAR (thoracic endovascular aortic repair) and Charing Cross delegates heard the results from a collaborative study that pooled practice data from a number of high-volume centres in order to benefit patients undergoing the procedure. A highlight of the session was the […]

STEP seeks to advance patient safety after TEVAR2018-04-27T10:06:45+01:00

Paclitaxel-eluting stent fails BATTLE against bare metal stent

2018-04-25T10:29:09+01:00

Yann Gouëffic

The BATTLE trial comparing a drug-eluting stent (Zilver PTX, Cook) vs. a bare metal stent (Misago, Terumo) for the treatment of intermediate femoropopliteal lesions has failed to the show superiority of the paclitaxel-coated stent at one-year follow-up. The trial highlights a need for further direct […]

Paclitaxel-eluting stent fails BATTLE against bare metal stent2018-04-25T10:29:09+01:00

CX@CEC: Focus on challenging aortic disease

2019-09-09T09:26:03+01:00

Rodney White

This year’s annual China Endovascular Course (CEC; 2–5 November, Beijing, China) played host to the first CX@CEC session, in collaboration with the Charing Cross Symposium. Focused on complex aortic disease, this session featured a selection of international and Chinese experts […]

CX@CEC: Focus on challenging aortic disease2019-09-09T09:26:03+01:00

CX 2018: Acute Stroke to explore the greatest carotid controversies of the day

2018-03-27T17:26:38+01:00

Ross Naylor at CX 2017

CX 2018 will close with the Acute Stroke CONTROVERSIES programme, which Ross Naylor—a member of the CX Programme Organising Board—promises will be a memorable session. The highlight will be five debates that will address a few “sacred cows” that arouse considerable controversy around […]

CX 2018: Acute Stroke to explore the greatest carotid controversies of the day2018-03-27T17:26:38+01:00

CX 2018: “I believe delegates of CX 2018 should attend this presentation since the information provided by it will change their practice”

2019-09-09T09:29:42+01:00

Juan Parodi (San Isidro, Argentina) gives an opening talk at CX 2018 “Reversal of lower extremity intermittent claudication and rest pain by hydration”. Come to CX on Day 1 to see if it as simple as that! Read the interview below for more information.

What are the limitations […]

CX 2018: “I believe delegates of CX 2018 should attend this presentation since the information provided by it will change their practice”2019-09-09T09:29:42+01:00

The opportunity for discussion is a key benefit of CX

2018-02-15T14:35:40+00:00

Fabrizio Fanelli (Florence, Italy), CX Faculty, says that a key point about CX is that it – unlike other meetings – provides opportunities for discussion. He notes that the “active discussion” at the podium is “very important” for what you learn at the meeting. Register for CX 2018!

[…]

The opportunity for discussion is a key benefit of CX2018-02-15T14:35:40+00:00

“Excellent” is the word Prof Davies uses to describe CX

2018-02-15T14:27:22+00:00

CX programme organising board member Alun Davies (Imperial College, London, United Kingdom) reviews how CX has changed in the last 24 years that he has been attending the symposium, his most memorable moments, and the one word he would use to describe the meeting. Register for CX 2018!

[…]

“Excellent” is the word Prof Davies uses to describe CX2018-02-15T14:27:22+00:00

“Every time I come to CX, I learn more and more”

2018-02-15T14:20:26+00:00

“One of the great things” about CX, according to CX Faculty member Kathleen Gibson (Bellevue, United States), is that it provides a “global perspective”. She says she “learns more and more” every time she attends. Register for CX 2018!

“Every time I come to CX, I learn more and more”2018-02-15T14:20:26+00:00

CX is “a very good forum” for new technologies

2018-02-15T13:13:21+00:00

Rodney White (Torrance, United States), CX Faculty, says that CX has been a “very good forum” for not only new technologies but also how we adapt them to current practice. He notes that CX chairman Roger Greenhalgh has always been at the forefront of the latest developments. Register for CX 2018! 

CX is “a very good forum” for new technologies2018-02-15T13:13:21+00:00
Go to Top